Valence ロゴ
人気
ログイン
Loading data for HRTS — first visit, this takes a few seconds.

ウォッチリストに追加

Tema Heart & Health ETF

NasdaqGM: HRTS · リアルタイム株価 · USD
38.55
+0.21 (0.55%)
終値時点： Aug 21, 2026, 8:00 PM
38.55
+0.10%
時間外: 4:10 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

Tema Heart & Health ETF（HRTS）の株価・分析・データ

0.55%

データがありません

買気配26.28
時価総額n/a
売上高（TTM）n/a
純利益（TTM）n/a
n/a
n/a
26.21
n/a
PBR（TTM）n/a
PSR（TTM）n/a
決算発表日n/a
売気配47.47
出来高2,240
平均出来高（20日）5,850
始値38.60
前日終値38.34
当日レンジ38.48 - 38.73
52週レンジ29.18 - 38.87
アナリストn/a
目標株価n/a
配当n/a
権利落ち日n/a

HRTSについて

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected ...

[続きを読む]
業種 n/a
セクター n/a
IPO日 Nov 21, 2023
従業員数 n/a
上場取引所 NasdaqGM
ティッカー HRTS
企業情報の全文

業績

undefined年のTema Heart & Health ETFの売上高はn/aで、前年のn/aからundefined%の増加でした。 利益はn/aで、undefined%の増加でした。

財務諸表
news image

1か月前 · Zacks

Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage

Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified way to tap growth across the obesity treatment market.

news image

2か月前 · Zacks

Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market

GLP-1 drugs are reshaping healthcare and consumer markets. These ETFs offer targeted exposure to the booming obesity-drug trend.

news image

3か月前 · Zacks

GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain

Eli Lilly and Novo Nordisk are accelerating global obesity pill launches as rising GLP-1 demand puts weight-loss ETFs in focus.